HES5 and neoplasm: We confirmed loss of Hes5 mRNA in the majority of tumour cells and thereby excluded the possibility that the minority of cells deleted for Ptc1 but not for RBP-J may have had a growth advantage and populated the tumour mass (Figure 4K,L).